Potential of in vitro reconstituted 3D human airway epithelia (MucilAir™) to assess respiratory sensitizers

Toxicology in Vitro

Volumn 27, Issue 3, 2013, Pages 1151-1156

  Huang, Song ^a   Wiszniewski, Ludovic ^a   Constant, Samuel ^a   Roggen, Erwin ^b  

^a Epithelix   (Switzerland)

^b NOVOZYMES A S   (Denmark)

Author keywords

Airway epithelia; Biomarkers; In vitro assay; MucilAir; Respiratory sensitization

Indexed keywords

CHEMICAL COMPOUND; DEXTRAN; HEXACHLOROPLATINATE AMMONIUM; INTERLEUKIN 6; INTERLEUKIN 8; IRRITANT AGENT; METHYLENE DIPHENYL DIISOCYANATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHENOL; RANTES; SALICYLIC ACID; TRIMELLITIC ANHYDRIDE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDICAL DEVICE; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; RELIABILITY; RESPIRATORY EPITHELIUM; SENSITIVITY ANALYSIS; SENSITIZATION; SURFACE PROPERTY; THREE DIMENSIONAL IMAGING; UPREGULATION; VALIDATION PROCESS;

ALLERGENS; BIOLOGICAL ASSAY; CYTOKINES; DEXTRANS; DRUG CARRIERS; HUMANS; IRRITANTS; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY MUCOSA;

EID: 84875381406     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.10.010     Document Type: Article

References (41)

1. Allahverdian S., Harada N., Singhera G.K., Knight D.A., Dorscheid D.R. Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF. Am. J. Respir. Cell Mol. Biol. 2008, 38:153-160.
2. Aptula A.O., Roberts D.W. Mechanistic applicability domains for non-animal-based prediction of toxicological end points: general principles and application to reactive toxicity. Chem. Res. Toxicol. 2006, 19:1097-1105.
3. Atherton H.C., Jones G., Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:730-739.
4. Balaci L., et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 2007, 80:1103-1114.
5. Baltimore D. NF-kB is 25. Nat. Immunol. 2011, 12:683-685.
6. Barnes P.J., Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336:1066-1071.
7. Barnes K.C., Marsh D.G. The genetics and complexity of allergy and asthma. Immunol. Today 1998, 19:325-332.
8. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
9. Booth B.W., Sandifer T., Martin E.L., Martin L.D. IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir. Res. 2007, 8:51.
10. Brochner B., 2003. Leukocyte recruitment in allergic pulmonary inflammation. In: Tony Eissa N., Huston D.P. (Eds), In Terapeutic Targets in Airway Inflammation, Lung Biology in Health and Disease, 177, 223-247.
11. Caamano J., Hunter C.A. NF-κB Family of Transcription Factors: central regulators of innate and adaptive immune functions. Clin. Microbiol. Rev. 2002, 15(3):414-429.
12. Chung K.F., Barnes P.J. Cytokines in asthma. Thorax 1999, 54:825-857.
13. Epstein M.M. Modeling allergic asthma: from in vitro assays to virtual patients. Drug Discov. Today: Dis. Models 2004, 1:387-394.
14. Evans G.S., et al. Chemical pollution, respiratory allergy and asthma: a perspective. J. Appl. Toxicol. 2008, 28(1):1-5.
15. Hopkin J.M. Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr. Opin. Immunol. 1997, 9(6):788-792.
16. Gerrard J.Y., Ko C.G., Vikers P., Gerrard C.D. The familial incidence of allergic disease. Ann. Allergy 1976, 36:10-15.
17. Hart L.A., Krishnan V.L., Adcock I.M., Barnes P.J., Chung K.F. Activation and localization of transcription factor, nuclear factor-kB, in asthma. Am. J. Respir. Crit. Care Med. 1998, 158:1585-1592.
18. Holgate S.T. Genetic and environmental interaction in allergy and asthma. J. Allergy Clin. Immunol. 1999, 104:1139-1146.
19. Holgate S.T. The airway epithelium is central to the pathogenesis of asthma. Allergol. Int. 2008, 57:1-10.
20. Holtzman M.J., et al. Immunity, inflammation, and remodelling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol. Rev. 2002, 82:19-46.
21. Isola D., et al. Chemical respiratory allergy and occupational asthma: what are the key areas of uncertainty?. J. Appl. Toxicol. 2008, 28(3):249-253.
22. Kimber I., Dearman R.J., Scholes E.W., Basketter D.A. The local lymph node assay: developments and applications. Toxicology 1994, 93:13-31.
23. Kimber I., Basketter D.A., Berthold K., Butler M., Garrigue J.-L., Lea L., Newsome C., Roggeband R., Steiling W., Stropp G., et al. Skin sensitization testing in potency and risk assessment. Toxicol. Sci. 2001, 59:198-208.
24. Kimber I., Dearman R.J. What makes a chemical a respiratory sensitizer?. Curr. Opin. Allergy Clin. Immunol. 2005, 5(2):119-124.
25. Kimber I., Dearman R.J. Cell and molecular biology of chemical allergy. Clin. Rev. Allergy Immunol. 1997, 15:145-168.
26. Kimber I., Dearman R.J. Immunobiology of chemical respiratory sensitization. Toxicology of Chemical Respiratory Allergy 1997, 73-106. Taylor and Francis, London, UK. I. Kimber, R.J. Dearman (Eds.).
27. Kimber I., Basketter D.A., Gerberick G.F., Ryan C.A., Dearman R.J. Chemical allergy: translating biology into hazard characterization. Toxicol. Sci. 2011, 120(S1):S238-S268.
28. Marsh D.G., Neely J.D., Breazeale D.R., Ghosh B., Freidhoff L., Ehrlich-Kautzky E., Schous C., Krishnaswamy G., Beaty T.H. Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum IgE concentrations. Science 1994, 264:1152-1156.
29. Maurano M.T., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
30. Murphy T.L., Cleveland M.G., Kulesza P., Magram J., Murphy K.M. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol. 1995, 15(10):5258-5267.
31. Natsch A. The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers - functional relevance and a hypothesis on innate reactions to skin sensitizers. Toxicol. Sci. 2010, 113:284-292.
32. Postma D.S., Bleeker E.R., Amelung P.J., Holroyd K., Xu J., Panhusen C.I.M., Meyers D., Levitt R.C. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy. N. Engl. J. Med. 1995, 333:894-900.
33. Roberts D.W., Aptula A.O. Determinants of skin sensitisation potential. J. Appl. Toxicol. 2008, 28:377-387.
34. Roberts D.W., Aptula A.O., Patlewicz G., 2007. Electrophilic chemistry related to skin sensitization. Reaction mechanistic applicability domain classification for a published dataset of 106.
35. Roggen E.L., Kristensen Soni N., Verheyen G.R. Respiratory immunotoxicity: an in vitro assessment. Toxicol. In Vitro 2006, 20:1249-1264.
36. Ruland J. Return to homeostasis: downregulation of NF-κB responses. Nat. Immunol. 2011, 12:709-714.
37. Smale S.T. Hierarchies of NF-κB target-gene regulation. Nat. Immunol. 2011, 12:689-694.
38. Verstraelen S., Bloemen K., Nelissen I., Witters H., Schoeters G., Van Den Heuvel R. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol. In Vitro 2008, 22:1419-1431.
39. Verstraelen S., Nelissen I., Hooyberghs J., Witters H., Schoeters G., Van Cauwenberge P., Van Den Heuvel R. Gene profiles of a human alveolar epithelial cell line after in vitro exposure to respiratory (non-) sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol. Lett. 2009, 185(1):16-22.
40. Walter M.J., Kajiwara N., Karanja P., et al. IL-12 p40 production by barrier epithelial cells during airway inflammation. J. Exp. Med. 2001, 193:339-352.
41. Ying S., Kay A. Chemokines in allergic asthma. Chemokines in Allergic Disease 2000, 383-402. Marcel Dekker, New York. M.E. Rothenberg (Ed.).